Stokes Frank's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Aug 13, 2024
- Accession no.
- 0001447362-24-000129
- Filed
- Aug 13, 2024
- Trade date
- Aug 7, 2024
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $257.0K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stokes FrankCIK 0001782815 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2024 | Common Stock | SSaleDisposed | −4,600 | $25.20 | −$115,920 | 36,223 | Direct | |
| Aug 7, 2024 | Common Stock | SSaleDisposed | −5,400 | $26.13 | −$141,102 | 30,823 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.